Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

Pre‐emptive pharmacogenetics (PGx) testing of a panel of germline genetic variants represents a new model for personalized medicine. Clinical impact of PGx testing is maximized when all variant alleles for which actionable clinical guidelines are available are included in the test panel. However, no...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Pharmacol Ther
Main Authors: van der Wouden, Cathelijne H., van Rhenen, Mandy H., Jama, Wafa O.M., Ingelman‐Sundberg, Magnus, Lauschke, Volker M., Konta, Lidija, Schwab, Matthias, Swen, Jesse J., Guchelaar, Henk‐Jan
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6771671/
https://ncbi.nlm.nih.gov/pubmed/31038729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1489
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares